CSIMarket
 


Dariohealth Corp   (DRIO)
Other Ticker:  
 
 

DRIO's Operating Income Growth by Quarter and Year

Dariohealth 's Operating Income results by quarter and year




DRIO Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 14.22 9.01 131.32 -9.06
III Quarter September 15.55 14.57 -22.50 -6.60
II Quarter June 14.02 17.36 -18.00 -4.12
I Quarter March 12.41 15.87 -14.33 -10.11
FY   56.20 56.81 76.49 -29.89



DRIO Operating Income fourth quarter 2023 Y/Y Growth Comment
Dariohealth Corp achieved in the fourth quarter 2023, above Company average Operating Income rise of 57.77% year on year, to $ 14.22 millions.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 45 other companies have achieved higher Operating Income growth. While Dariohealth Corp ' s Operating Income jump of 57.77% ranks overall at the positon no. 1721 in the fourth quarter 2023.

Explain Operating Income growth


DRIO Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 57.77 % -93.14 % - -
III Quarter September 6.73 % - - -
II Quarter June -19.24 % - - -
I Quarter March -21.8 % - - -
FY   -1.08 % -25.73 % - -

Financial Statements
Dariohealth 's fourth quarter 2023 Operating Income $ 14.22 millions DRIO's Income Statement
Dariohealth 's fourth quarter 2022 Operating Income $ 9.01 millions Quarterly DRIO's Income Statement
New: More DRIO's historic Operating Income Growth >>


DRIO Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -8.59 % -38.16 % - -
III Quarter September 10.91 % -16.07 % - -
II Quarter June 12.97 % 9.39 % - -
I Quarter March 37.74 % -87.92 % - -
FY (Year on Year)   -1.08 % -25.73 % - -




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #46
Healthcare Sector #118
Overall #1721

Operating Income Y/Y Growth Statistics
High Average Low
166.43 % -36.35 % -249.85 %
(Sep 30 2019)   (Sep 30 2020)
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #46
Healthcare Sector #118
Overall #1721
Operating Income Y/Y Growth Statistics
High Average Low
166.43 % -36.35 % -249.85 %
(Sep 30 2019)   (Sep 30 2020)

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Dariohealth 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
68.45 % 1.89 % -87.91 %
(Sep 30 2015)  


DRIO's IV. Quarter Q/Q Operating Income Comment
In the IV. Quarter 2023 Dariohealth Corp disclosed drop in Operating Income from the previous quarter by -8.59% to $ 14.22 millions, from $ 15.55 millions released in the previous quarter.

If you look into recent downturn in the IV. Quarter 2023, you suppose to assume, that frequently IV. Quarter Operating Income appear to be weaker relative to the preciding period, José Nuno Martins, a business observer mentioned.

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Operating Income quarter on quarter growth. While Dariohealth 's Operating Income growth quarter on quarter, overall rank is 978.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #73
Overall #978
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #73
Overall #978
Operating Income Q/Q Growth Statistics
High Average Low
68.45 % 1.89 % -87.91 %
(Sep 30 2015)  


DRIO's IV. Quarter Q/Q Operating Income Comment
In the IV. Quarter 2023 Dariohealth Corp realized drop in Operating Income sequentially by -8.59% to $ 14.22 millions, from $ 15.55 millions released in the previous reporting period.

When you look into recent shortcoming in the quarter, you must take into consideration, that frequently IV. Quarter Operating Income appear to be weaker in contrast to the quarter before, José Nuno Martins, a business observer mentioned.

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Operating Income quarter on quarter growth. While Dariohealth 's Operating Income growth quarter on quarter, overall rank is 978.


Dariohealth 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ 56.19 $ 50.98 $ 50.01 $ 53.35 $ 56.81
Y / Y Operating Income Growth (TTM) -1.09 % -71.54 % -64.79 % -50 % -25.73 %
Year on Year Operating Income Growth Overall Ranking # 1390 # 1625 # 1546 # 1480 # 1395
Seqeuential Operating Income Change (TTM) 10.21 % 1.95 % -6.25 % -6.1 % -68.28 %
Seq. Operating Income Growth (TTM) Overall Ranking # 1721 # 612 # 532 # 468 # 353




Cumulative Operating Income growth Comment
Dariohealth showed decline, but improvement compare to trailing twelve month Operating Income decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Dariohealth 's annual Operating Income drop would be -1.09% year on year to $56 millions.

In the Healthcare sector 98 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1390, from total ranking in previous quarter at 1625.

Operating Income TTM Q/Q Growth Statistics
High Average Low
166.43 %
-36.35 %
-249.85 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 46
Healthcare Sector # 99
Overall # 1390

Operating Income TTM Y/Y Growth Statistics
High Average Low
166.43 %
-36.35 %
-249.85 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 46
Sector # 118
S&P 500 # 1721
Cumulative Operating Income growth Comment
Dariohealth showed decline, but improvement compare to trailing twelve month Operating Income decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Dariohealth 's annual Operating Income drop would be -1.09% year on year to $56 millions.

In the Healthcare sector 98 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1390, from total ranking in previous quarter at 1625.

Operating Income TTM Q/Q Growth Statistics
High Average Low
166.43 %
-36.35 %
-249.85 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 46
Healthcare Sector # 99
Overall # 1390

Operating Income TTM Y/Y Growth Statistics
High Average Low
166.43 %
-36.35 %
-249.85 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 46
Sector # 118
S&P 500 # 1721




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
DRIO's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for DRIO's Competitors
Operating Income Growth for Dariohealth 's Suppliers
Operating Income Growth for DRIO's Customers

You may also want to know
DRIO's Annual Growth Rates DRIO's Profitability Ratios DRIO's Asset Turnover Ratio DRIO's Dividend Growth
DRIO's Roe DRIO's Valuation Ratios DRIO's Financial Strength Ratios DRIO's Dividend Payout Ratio
DRIO's Roa DRIO's Inventory Turnover Ratio DRIO's Growth Rates DRIO's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Quest Diagnostics Inc97.78%$ 97.778 millions
3m Company96.68%$ 96.677 millions
Elite Pharmaceuticals Inc 80.32%$ 80.320 millions
Dr Reddy s Laboratories Limited78.66%$ 78.663 millions
Electromed Inc 77.63%$ 77.630 millions
Eli Lilly And Company74.93%$ 74.935 millions
Dexcom Inc 72.97%$ 72.967 millions
Sotera Health Company72.89%$ 72.889 millions
Dariohealth Corp 57.77%$ 57.769 millions
Alcon inc 54.61%$ 54.613 millions
Stryker Corp54.42%$ 54.423 millions
Align Technology inc 52.27%$ 52.267 millions
Davita Inc 52.16%$ 52.158 millions
Healthcare Services Group Inc 51.40%$ 51.399 millions
Tactile Systems Technology Inc 50.32%$ 50.318 millions
Viemed Healthcare Inc 49.66%$ 49.660 millions
United Therapeutics Corporation48.12%$ 48.121 millions
Lemaitre Vascular Inc 46.49%$ 46.491 millions
Neurocrine Biosciences Inc 45.36%$ 45.358 millions
Boston Scientific Corporation45.27%$ 45.274 millions
Msa Safety Incorporated44.79%$ 44.789 millions
Corcept Therapeutics Inc40.76%$ 40.757 millions
Powerup Acquisition Corp 39.00%$ 38.999 millions
Tenet Healthcare Corp37.13%$ 37.127 millions
Chemed Corporation36.97%$ 36.971 millions
Abbott Laboratories36.50%$ 36.503 millions
Nature s Sunshine Products inc 36.49%$ 36.490 millions
Halozyme Therapeutics Inc 35.60%$ 35.601 millions
Catalyst Pharmaceuticals Inc 35.36%$ 35.359 millions
Iqvia Holdings Inc 32.19%$ 32.190 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com